当前位置: 首页 > 期刊 > 《医药产业资讯》 > 20206
编号:13503847
肝窦内皮细胞相关文献的可视化分析(4)
http://www.100md.com 2020年2月25日 《中国医药导报》 20206
     [9] Xie G,Wang X,Wang L,et al. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats [J]. Gastroenterology,2012,142(4):918-927.

    [10] Knolle PA,Gerken G. Local control of the immune response in the liver [J]. Immunol Rev,2000,4(174):21-34.

    [11] Fraser R,Cogger VC,Dobbs B,et al. The Liver Sieve and Atherosclerosis [J]. Pathology,2012,44(3):181-186.

    [12] Rogers GW,Dobbs BR,Fraser R. Decreased hepatic uptake of cholesterol and retinol in the dimethylnitrosamine rat model of cirrhosis [J]. Liver,1992,12(5):326-329.

    [13] Fraser R,Dobbs BR,Rogers GW. Lipoproteins and the liver sieve:the role of the fenestrated sinusoidal endothelium in lipoproteinmetabolism,atherosclerosis,and cirrhosis [J]. Hepatology,1995,21(3):863-874.

    [14] Kanazawa H,Obara H,Yoshikawa R,et al. Impact of machine perfusion on sinusoid microcirculation of liver graft donated after cardiac death [J]. J Surg Res,2019, 19(245):410-419.

    [15] Yang XQ,Ye J,Li X,et al. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis,clinical manifestations,diagnosis,treatment,and outcomes [J]. World J Gastroenterol,2019,25(28):3753-3763.

    [16] Gracia-Sancho J,Manicardi N,Ortega-Ribera M,et al. Emricasan ameliorates portal hypertension and liver fibrosis in cirrhotic rats through a hepatocyte-mediated paracrine mechanism [J]. Hepatol Commun,2019,3(7):987-1000.

    (收稿日期:2019-09-03 本文編辑:李亚聪), 百拇医药(闫晓宇 刘俞彤 吕文良)
上一页1 2 3 4